Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Pyridostigmine (Atc Code: N07aa02).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Rivaroxaban (Atc Code: B01af01).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Filgrastim, Atc L03aa02 for the Period April 1St, 2024 - March 31St, 2026

Open House Drug Discount Agreements Fingolimod in the Potency 0.25 Mg, Atc L04ae01

Open House Drug Discount Agreements Rivaroxaban Hard Capsules (Except in the Strength 2.5 Mg), Atc B01af01

Open House Drug Discount Agreements Omalizumab, Atc R03dx05

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Interferon Beta-1B, Atc L03ab08 for the Period April 1St, 2024 - March 31St...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dexamethasone (Exclusively Imp), Atc S01ba01 for the Period April 1St, 2024...

Open House Drug Discount Agreements Rivaroxaban with a Potency of 2.5 Mg Film-Coated Tablets and Hard Capsules, Atc B01af01

Open House Drug Discount Agreements Cladribine, Atc L04aa40